Merck and Millipore announce acquisition agreement
March 5, 2010
Millipore and Merck will thus create a biotechnology of 2.1 billion euros, at global level, society which will achieve a significant level in the business of specialities with high margin and an attractive growth profile.
Millipore holds a strong position in attractive segments of the bioinvestigación and the bioproduction, and offers a wide range of products, technologies and services for Pharma and Biotech companies, and also the academic sector, aimed at the improvement of productivity in the laboratory and the development and optimization of manufacturing processes.
With this merger, Millipore and Merck shall have a significant presence in high growth segments and a stronger geographic presence. By combining the capacities of research and development of the two companies, establishing a powerful platform for innovation, capable of developing leading-edge technologies, further tailored to the needs of customers.